Incidence and Prevalence of Type 1 Diabetes Mellitus among Korean Children and Adolescents between 2007 and 2017: An Epidemiologic Study Based on a National Database

Hyun Wook Chae; Gi Hyeon Seo; Kyungchul Song; Han Saem Choi; Junghwan Suh; Ahreum Kwon; Sangmi Ha; Ho-Seong Kim

doi:10.4093/dmj.2020.0212

Journal List > Diabetes Metab J > v.44(6) > 1145342

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Chae, Seo, Song, Choi, Suh, Kwon, Ha, and Kim: Incidence and Prevalence of Type 1 Diabetes Mellitus among Korean Children and Adolescents between 2007 and 2017: An Epidemiologic Study Based on a National Database

Original Article

Type 1 Diabetes

Diabetes Metab J 2020;44(6):866-874.

Published online: 4 November 2020

DOI: https://doi.org/10.4093/dmj.2020.0212

Incidence and Prevalence of Type 1 Diabetes Mellitus among Korean Children and Adolescents between 2007 and 2017: An Epidemiologic Study Based on a National Database

Hyun Wook Chae^1,^*

, Gi Hyeon Seo^2,^*

, Kyungchul Song¹, Han Saem Choi¹, Junghwan Suh¹, Ahreum Kwon¹, Sangmi Ha², Ho-Seong Kim¹

¹Department of Pediatrics, Endocrine Research Institute, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul, Korea

²Korean Health Insurance Review and Assessment Service, Seoul, Korea

Corresponding author: Ho-Seong Kim Department of Pediatrics, Endocrine Research Institute, Severance Children’s Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail: kimho@yuhs.ac

^* Hyun Wook Chae and Gi Hyeon Seo contributed equally to this study as first authors.

Received 25 August 2020 Accepted 7 October 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The incidence of type 1 diabetes mellitus (T1DM) among children is high in Europe and the USA and relatively low in Asia, including Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea and examine trends in incidence.

Methods

This study was conducted using the national registry data provided by the Health Insurance Review and Assessment Service in Korea from 2007 to 2017. We included children aged 0 to 14 years who were newly registered with a T1DM diagnosis each year (code E10).

Results

A total of 29,013 children were registered. The overall incidence of T1DM was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea increased from 3.70 in 2008 to 4.77 in 2016 (P=0.002). The incidence of T1DM increased from 3.07 in 2008 to 4.89 in 2016 (P<0.001) among boys. Although the incidence of the disease increased significantly among boys aged 5–9 and 10–14 years, it remained constant among girls (4.39 in 2008, 4.64 in 2016). The overall prevalence of childhood-onset T1DM in Korea increased from 32.85 in 2007 to 41.03 per 100,000 persons in 2017 (girls, 35.54 to 43.88; boys, 32.85 to 41.03).

Conclusion

We calculated relatively accurate incidence and prevalence of childhood-onset T1DM from a nation-based registry. The incidence increased by 3% to 4% every year from 2007 to 2017. The increasing trend is noteworthy compared with previous reports.

Keywords: Diabetes mellitus, type 1, Epidemiology, Incidence, Prevalence

INTRODUCTION

Childhood-onset type 1 diabetes mellitus (T1DM) is a prevalent pediatric endocrine disease. The incidence and prevalence of T1DM among children are high in Europe (particularly in Scandinavian countries) and the United States of America and relatively low in Asia. The incidence of childhood-onset T1DM has remained less eminent in Asia than in Western countries owing to the paucity of long-term data obtained from population-based studies conducted in Asian countries, including Korea [1].

An increasing trend in the incidence of childhood-onset T1DM has been reported worldwide. The Diabetes Mondiale (DiaMond) Project Group reported an annual increase in T1DM incidence of 2.8% between 1990 and 1999 [2]. The European Diabetes (EURODIAB) study showed that the incidence of T1DM in Europe increased by approximately 3.9% annually between 1989 and 2003 [3]. The incidence and prevalence of T1DM and type 2 diabetes mellitus (T2DM) are increasing in many developing countries [4,5]. However, recent reports emanating from some countries suggest that this increasing trend has slowed. Studies conducted in Finland and Sweden demonstrated that the incidence of childhood-onset T1DM has ceased to increase in recent years [6,7]. In Norway, there was no significant increase in incidence between 2004 and 2012 [8]. Epidemiological data on T1DM among children and adolescents are still lacking for most of the global population, particularly in Africa, Asia, and South America [2]. Few comprehensive population-based studies of diabetes have investigated children and adolescents of diverse ethnic backgrounds. A few studies have forecasted that the prevalence of childhood-onset T1DM will increase mostly in developing countries, even though the incidence has remained low [9,10]. Surveillance of the incidence and prevalence of childhood-onset T1DM should be conducted not only to understand its complex etiology but also to recognize the implications for public health [11].

Although several epidemiologic studies have been conducted, it is unclear whether the estimates of incidence and prevalence of T1DM among children and adolescents are accurate and whether the incidence is increasing in Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea using the nationwide registry data provided by the Health Insurance Review and Assessment Service (HIRA). We also investigated the annual trend in the incidence of childhood-onset T1DM during the past decade and analyzed the data according to age and sex.

METHODS

Patients and study design

The present retrospective population-based study aimed to investigate the incidence and prevalence of childhood-onset T1DM among Korean children through a complete enumeration survey using the HIRA claims data from January 1, 2007 to December 31, 2017. The study design and enrollment of subjects are shown in Fig. 1. Korea has a national health insurance system that provides medical insurance coverage to all its inhabitants, and each individual is registered with a health insurance identification number. Every resident is eligible regardless of nationality or profession. The system is funded by compulsory contributions from all residents and government subsidies. All Korean patients who visit a hospital are registered with a diagnosis according to the World Health Organization’s International Classifications of Diseases, Tenth Revision (ICD-10). The HIRA reviews the data to ensure proper diagnoses and management and to assess the quality of healthcare and medical fees.

In calculating the incidence of T1DM, we included boys and girls who were newly registered with a diagnostic code of E10 according to the ICD-10 before the age of 15 years and were treated only with insulin, as done in other studies of the pediatric population. We excluded children who were injected with insulin before 2008 and patients who were not treated with insulin continuously for 2 consecutive years after diagnosis to rule out patients with T2DM. In estimating the prevalence, we included children who were registered with a diagnostic code of E10 before the age of 15 years and received at least two prescriptions of insulin over 12 months with continuous insulin treatment in the following year. The diagnosis of T1DM was confirmed with a thorough review of the medical records of all cases by medical personnel of the HIRA.

Ethics statement

The study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Severance Hospital, Seoul, Korea, and written informed consents from the subjects were exempted by the IRB (no. 4-2019-0088).

Calculation of incidence and prevalence

We calculated the incidence of T1DM by dividing the number of children who were newly diagnosed with T1DM during a calendar year by the total number of children at risk living in Korea during that calendar year. Exact confidence intervals for incidence were calculated using the Ulm’s formula [12]. In addition, we calculated the prevalence of T1DM by dividing the number of children registered with a diagnosis of T1DM during a calendar year by the total number of children living in Korea during that calendar year. The 95% confidence intervals of the prevalence with a 0.05 significance level were also calculated using the formula

p \pm 1.96 \sqrt{\frac{p (1 - p)}{n}}

(where, p is the prevalence and n is the sample size). Gender- and age-specific incidence and prevalence of T1DM were calculated using the population data obtained from the Korean Statistical Information Service, 2015 (http://kosis.kr/). Both the incidence and prevalence were calculated per 100,000 inhabitants according to age and gender. A Cochran–Armitage test for trend was used to investigate and compare the time trends in incidence by sex and age group (0–4, 5–9, and 10–14 years). Analysis items with P<0.05 were considered statistically significant.

RESULTS

A total of 29,013 children were registered from January 2007 to December 2017. The annual incidences of T1DM according to gender from 2008 to 2016 are shown in Table 1. The overall incidence of T1DM during the study period was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea increased significantly from 3.70 per 100,000 persons in 2008 to 4.77 per 100,000 persons in 2016 (P=0.002). The incidence of T1DM among boys increased from 3.07 per 100,000 persons in 2008 to 4.89 per 100,000 persons in 2016 (P<0.001). However, the incidence was not definite among girls during the study period (4.39 per 100,000 persons in 2008 and 4.64 per 100,000 persons in 2016). There was an increasing trend in gender-specific annual incidence of childhood-onset T1DM in Korea (Fig. 2). The incidence increased by approximately 3% to 4% every year from 2007 to 2017.

The annual incidence of T1DM according to gender and age group is shown in Table 2. The overall incidence of childhood-onset T1DM increased significantly among children aged 10 to 14 years. The incidence increased significantly among boys aged 5–9 and 10–14 years; however, it was indefinite among boys aged 0 to 4 years. The incidence of T1DM increased from 1.16 to 3.72 per 100,000 persons among boys aged 5 to 9 years and from 5.53 to 8.90 per 100,000 persons among boys aged 10 to 14 years between 2008 and 2016 (P=0.040 and P<0.001, respectively). The incidence of T1DM among girls did not increase significantly in all age groups.

The distribution of the annual prevalence of T1DM according to age group is shown in Table 3. The overall prevalence of childhood-onset T1DM in Korea increased significantly from 32.85 to 41.03 per 100,000 persons between 2007 and 2017 (girls, 35.54 to 43.88 per 100,000 persons; boys, 32.85 to 41.03 per 100,000 persons). The annual prevalence increased rapidly over the last 2 years of the study period.

We analyzed the cumulative distribution of the incidence of disease according to months from 2008 to 2016. The incidence appeared to be relatively high in March, April, and June and low in November and December. However, this seasonal difference was not significant statistically (Fig. 3).

DISCUSSION

This work was a retrospective national registry-based epidemiologic study of the incidence and prevalence of childhood-onset T1DM in Korea from 2007 to 2017. The overall incidence of childhood-onset T1DM during the study period was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea (per 100,000 persons) increased significantly from 3.70 in 2008 to 4.77 in 2016 and by approximately 3% to 4% annually during the study period. The overall prevalence (per 100,000 persons) increased significantly from 32.85 in 2007 to 41.03 in 2017 (girls, 35.54 to 43.88; boys, 32.85 to 41.03). We found that the incidence and prevalence of childhood-onset T1DM in Korea were higher than those determined in previous studies conducted in Korea and increased significantly during the study period.

The global incidence of diabetes among children and adolescents is increasing rapidly due to an increase in incidence of childhood obesity regardless of region. However, there are some variations in the incidence of T1DM according to ethnicity and region. Approximately 193,000 Americans younger than 20 years are estimated to have been diagnosed with diabetes, representing approximately 0.24% of that population [13]. A nationwide survey conducted in the USA from 2001 through 2016 demonstrated that 45,047 people aged 19 or younger who had T1DM were identified, representing a 5.4 to 79.6 prevalence rate per 100,000 person-years according to the states [13]. The DiaMond Project Group reported that a very high incidence was found in European countries and North America, and the lowest incidence was found in the populations from China and South America in 2000 [14]. The EURODIAB study reported the incidence of childhood-onset T1DM in the first (1989 to 1998) and second (1999 to 2008) halves of the 20-year period. The increase in annual incidence rates were similar (3.4% and 3.3%, respectively), suggesting that the incidence rate of childhood-onset T1DM continues to rise across Europe but not uniformly so among the regions [15].

Asian countries showed relatively lower incidences of childhood-onset T1DM than did Europe and the USA. These geographic differences in T1DM incidence may reflect population variations in the frequency of T1DM susceptibility or protective genes and/or environmental factors or their combination [16]. Although the incidence of T1DM is relatively lower in Asian countries, increasing trends in the incidence of T1DM have also been observed in Asian regions. In Japan, the annual incidence of childhood-onset T1DM was 1.5 per 100,000 persons from 1986 to 1990 [17]. A more recent study conducted in Japan reported that the incidence of T1DM from 2005 to 2010 was 2.25 per 100,000 persons, suggesting that the incidence is increasing in Japan [1]. In China, the incidence in the Beijing area was 1.81 per 100,000 population during 2003 to 2010 [18]. In reports of a Taiwanese nationwide epidemiologic study, the incidence of childhood-onset T1DM (per 100,000 persons) was 3.56 among boys and 5.88 among girls in 1999 to 2000 and increased significantly with an incidence of 4.42 among boys and 6.92 among girls in 2009 to 2010 [19]. The present study showed higher incidence of T1DM in Korea compared with that of Japan and China, and lower than that of Taiwan. The incidence and prevalence of T1DM would differ from country to country due to variable factors including change of lifestyle, increase of obesity, and environmental immune system [20,21].

It is known that the incidence of childhood-onset T1DM is exceptionally low in Korea. A limited number of studies have estimated the incidence and prevalence of childhood-onset T1DM in Korea. The first nationwide survey on the incidence of T1DM among Korean children and adolescents was conducted as part of the Diabetes Epidemiology Research International Study from 1985 to 1986 and showed an incidence of 0.5 per 100,000 population in both sexes [22]. Another study reported an incidence of 1.36 per 100,000 during 1995 to 2000 [23]. The most recent report on the epidemiology of childhood-onset T1DM in Korea was performed using the data obtained from the National Health Insurance Service during 2012 to 2014 [24]. The incidence was 3.19 per 100,000 (2.84 and 3.56 among boys and girls, respectively), and it was relatively higher than that reported in previous studies conducted in Korea. The present study demonstrated a higher incidence and prevalence than previously reported estimates in Korea and a significant increase in incidence of childhood-onset T1DM. We confirmed that the increasing trend in incidence of childhood-onset T1DM was sustained in Korea.

In the present study, we found a higher incidence and prevalence among girls than among boys. However, the increase in the rate of incidence was higher among boys. It is known that boys are predominantly affected by T1DM after puberty [25]. The overall ratio of incidence of T1DM among boys to that among girls was 1:1; however, a ratio of 1:7 was reported among children aged 13 years in a study conducted in Finland [26]. Some reports have shown that childhood-onset T1DM is more common among male children and adolescents in European countries [27-29]. Compared with that of Western countries, the Japanese cohort presents a preponderance of girls than boys [17]. A report emanating from China showed a preponderance of girls with newly diagnosed T1DM; however, a higher rate of increase occurred among boys between 1995 and 2010, similar to that observed in the present study [30]. A report showed that female predominance is associated with a lower incidence and ethnic group [27]. This implies that there should be specific considerations according to certain ethnicities or regions, although the reasons remain to be clarified.

In the present study, the incidences of childhood-onset T1DM appeared to be higher in March, April, and June; however, this seasonal difference was not significant statistically. It has been reported that the incidence of T1DM is higher in the fall or winter seasons [31,32]. However, the seasonality pattern appears to depend on the geographical location, at least as far as the hemisphere dichotomy is concerned [33]. A Japanese cohort study revealed no seasonal variation compared with that of Western countries [17].

We found that the incidence of childhood-onset T1DM in Korea increased rapidly over the past decade. It is unclear why the incidence of childhood-onset T1DM is increasing in Korea; nevertheless, it is not remarkably higher than that of Western countries. Factors contributing to the development of T1DM include genetic factors, which involve familial and ethnic patterns, and various environmental factors. A westernized lifestyle and national prosperity could reflect differences in environmental risk factors such as nutrition or lifestyle that affect the incidence rate [34]. The “accelerator hypothesis” tried to explain the loss of beta cells and the increasing incidence of both types of diabetes associated with the childhood obesity epidemic in some way [35]. An increasing prevalence of obesity among Korean children may also yield a possible association with the increasing rate of childhood-onset T1DM [36]. An assessment of the risk factors for T1DM in the general population and further efforts aimed at elucidating the causes underlying the increase in incidence of T1DM among Korean children are needed.

Our study had some limitations. First, some T1DM patients might not be registered for various reasons, such as emigration or studying abroad. Second, there is a possibility of misclassification of childhood T1DM or T2DM. For example, early treatments of T2DM often include insulin injections besides oral hypoglycemic agents. We tried to exclude patients who were not treated with insulin continuously for 2 consecutive years after diagnosis; nonetheless, misclassification might be a confounding factor in the present study. Third, the prevalence might be overestimated. We included children who were registered with a diagnostic code of E10 and were treated with only insulin continuously more than once; however, we could not perfectly exclude some cases of T2DM. Despite these limitations, we believe that the inclusion and exclusion criteria in the present study might be the most practical way to achieve the study aim and we were able to calculate relatively accurate incidences and prevalence of childhood-onset T1DM using the nationwide data.

In conclusion, we calculated relatively accurate incidences and prevalence of childhood-onset T1DM according to the data obtained from a nationwide registry from the HIRA. We found that the incidence and prevalence of childhood-onset T1DM increased significantly at a rate of about 3% to 4% every year from 2007 to 2017. Further long-term studies with investigation of environmental factors and other possible contributing factors are needed to elucidate the increasing trend in the occurrence of childhood-onset T1DM in Korea.

Notes

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS

Conception or design: G.H.S., H.S.K.

Acquisition, analysis, or interpretation of data: H.W.C., G.H.S., S.H., H.S.K.

Drafting the work or revising: H.W.C., K.S., H.S.C., J.S., A.K., H.S.K.

Final approval of the manuscript: H.W.C., G.H.S., K.S., H.S.C., J.S., A.K., S.H., H.S.K.

FUNDING

None

ACKNOWLEDGMENTS

The authors thank the Yonsei Foreign Language Institute and Editage (www.editage.co.kr) for review and correction of the English version of the manuscript.

REFERENCES

1. Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, et al. Incidence and prevalence of childhood-onset type 1 diabetes in Japan: the T1D study. Diabet Med. 2017; 34:909–15.

2. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006; 23:857–66.

3. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009; 373:2027–33.

4. Aminzadeh M, Navidi N, Valavi E, Aletayeb SMH. Childhood onset type 1 diabetes at a tertiary hospital in south-western Iran during 2000-2015: rapid increase in admissions and high prevalence of DKA at diagnosis. Prim Care Diabetes. 2019; 13:43–8.

5. Viswanathan V, Sathyamurthy S. Global increase in the prevalence of diabetes with special reference to the Middle East and Asia. Diabetes Technol Ther. 2015; 17:676–8.

6. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA. 2013; 310:427–8.

7. Berhan Y, Waernbaum I, Lind T, Mollsten A, Dahlquist G; Swedish Childhood Diabetes Study Group. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes. 2011; 60:577–81.

8. Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G; Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia. 2014; 57:57–62.

9. Green A. Descriptive epidemiology of type 1 diabetes in youth: incidence, mortality, prevalence, and secular trends. Endocr Res. 2008; 33:1–15.

10. Basit A, Riaz M, Fawwad A. Improving diabetes care in developing countries: the example of Pakistan. Diabetes Res Clin Pract. 2015; 107:224–32.

11. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009; 373:1999–2000.

12. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990; 131:373–5.

13. Rogers MAM, Rogers BS, Basu T. Prevalence of type 1 diabetes among people aged 19 and younger in the United States. Prev Chronic Dis. 2018; 15:E143.

14. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000; 23:1516–26.

15. Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia. 2012; 55:2142–7.

16. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia. 2006; 49:828–36.

17. Kida K, Mimura G, Ito T, Murakami K, Ashkenazi I, Laron Z. Incidence of type 1 diabetes mellitus in children aged 0-14 in Japan, 1986-1990, including an analysis for seasonality of onset and month of birth: JDS study. The Data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Diabet Med. 2000; 17:59–63.

18. Gong C, Meng X, Saenger P, Wu D, Cao B, Wu D, et al. Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010. Horm Res Paediatr. 2013; 80:328–34.

19. Lin WH, Wang MC, Wang WM, Yang DC, Lam CF, Roan JN, et al. Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS One. 2014; 9:e86172.

20. Soltesz G, Patterson CC, Dahlquist G; EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence: what can we learn from epidemiology? Pediatr Diabetes. 2007; 8 Suppl 6:6–14.

21. Jarosz-Chobot P, Polanska J, Polanski A. Does social-economical transformation influence the incidence of type 1 diabetes mellitus? A Polish example. Pediatr Diabetes. 2008; 9:202–7.

22. Rewers M, LaPorte RE, King H, Tuomilehto J. Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in childhood. World Health Stat Q. 1988; 41:179–89.

23. Shin CH. Epidemiologic characteristics of type 1 diabetes in children aged 14 years or under in Korea, 1985-2000. Korean J Pediatr. 2008; 51:569–75.

24. Kim JH, Lee CG, Lee YA, Yang SW, Shin CH. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatr Diabetes. 2016; 17:519–24.

25. Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, et al. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia. 2004; 47:377–84.

26. Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008; 371:1777–82.

27. Karvonen M, Pitkaniemi M, Pitkaniemi J, Kohtamaki K, Tajima N, Tuomilehto J. Sex difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev. 1997; 13:275–91.

28. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health. 2009; 63:332–6.

29. Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, et al. Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes. 2010; 59:2281–7.

30. Gong C, Meng X, Jiang Y, Wang X, Cui H, Chen X. Trends in childhood type 1 diabetes mellitus incidence in Beijing from 1995 to 2010: a retrospective multicenter study based on hospitalization data. Diabetes Technol Ther. 2015; 17:159–65.

31. Van Wouwe JP, Jacobusse G, Van Buuren S. Seasonal variation in the diagnosis of type 1 diabetes. Diabetes Res Clin Pract. 2008; 79:e13.

32. Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, et al. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature. Pediatr Diabetes. 2015; 16:573–80.

33. Moltchanova EV, Schreier N, Lammi N, Karvonen M. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet Med. 2009; 26:673–8.

34. Patterson CC, Dahlquist G, Soltesz G, Green A; EURODIAB ACE Study Group. Europe and Diabetes. Europe and Diabetes. Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia. 2001; 44 Suppl 3:B9–16.

35. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia. 2001; 44:914–22.

36. Ha KH, Kim DJ. Epidemiology of childhood obesity in Korea. Endocrinol Metab (Seoul). 2016; 31:510–8.

Fig. 1.

Study design and number of subjects for investigating the incidence of type 1 diabetes mellitus (T1DM) in Korean children. ICD-10, World Health Organization’s International Classifications of Diseases, Tenth Revision.

Fig. 2.

Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus among Korean children.

Fig. 3.

Distribution of type 1 diabetes mellitus among Korean children according to month from 2008 to 2016.

Table 1.

Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus with confidence intervals among Korean children

Year	Girls			Boys			Total
Year	No. of cases	Population	Incidence (CI)	No. of cases	Population	Incidence (CI)	No. of cases	Population	Incidence (CI)
2008	181	4,120,183	4.39 (3.78–5.08)	139	4,521,648	3.07 (2.58–3.63)	320	8,881,760	3.70 (3.31–4.13)
2009	183	4,009,329	4.56 (3.93–5.28)	163	4,374,659	3.73 (3.18–4.34)	346	8,641,831	4.13 (3.70–4.59)
2010	200	3,898,029	5.13 (4.44–5.89)	155	4,231,154	3.66 (3.11–4.29)	355	8,383,987	4.37 (3.92–4.85)
2011	223	3,799,250	5.87 (5.12–6.69)	172	4,106,239	4.19 (3.59–4.86)	395	8,129,182	5.00 (4.52–5.51)
2012	175	3,710,279	4.72 (4.04–5.47)	155	3,998,855	3.88 (3.29–4.54)	330	7,905,489	4.28 (3.83–4.77)
2013	185	3,624,293	5.10 (4.40–5.90)	161	3,897,014	4.13 (3.52–4.82)	346	7,709,134	4.60 (4.13–5.11)
2014	195	3,541,088	5.51 (4.76–6.34)	163	3,795,828	4.29 (3.66–5.01)	358	7,521,307	4.88 (4.39–5.41)
2015	153	3,457,143	4.43 (3.75–5.19)	158	3,694,212	4.28 (3.64–5.00)	311	7,336,916	4.35 (3.88–4.86)
2016	157	3,380,577	4.64 (3.95–5.43)	176	3,601,440	4.89 (4.19–5.66)	333	7,151,354	4.77 (4.27–5.31)

CI, confidence interval.

Table 2.

Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus according to age group among Korean children

Variable	Year	Girls				Boys				Total
Variable	Year	0–4 years	5–9 years	10–14 years	0–14 years	0–4 years	5–9 years	10–14 years	0–14 years	0–4 years	5–9 years	10–14 years	0–14 years
No. of cases	2008	16	48	117	181	13	25	101	139	29	73	218	320
	2009	21	60	102	183	17	45	101	163	38	105	203	346
	2010	23	60	117	200	20	37	98	155	43	97	215	355
	2011	22	59	142	223	21	48	103	172	43	107	245	395
	2012	16	50	109	175	19	35	101	155	35	85	210	330
	2013	27	46	112	185	16	39	106	161	43	85	218	346
	2014	35	49	111	195	22	35	106	163	57	84	217	358
	2015	26	42	85	153	23	34	101	158	49	76	186	311
	2016	15	56	86	157	20	45	111	176	35	101	197	333
Incidence	2008	1.44	3.49	7.17	4.39	1.09	1.66	5.53	3.07	1.26	2.53	6.30	3.70
	2009	1.91	4.59	6.37	4.56	1.45	3.16	5.69	3.73	1.67	3.84	6.02	4.13
	2010	2.08	4.89	7.47	5.13	1.70	2.78	5.69	3.66	1.88	3.79	6.53	4.37
	2011	1.96	5.12	9.31	5.87	1.76	3.85	6.18	4.19	1.86	4.46	7.68	5.00
	2012	1.42	4.43	7.50	4.72	1.59	2.88	6.37	3.88	1.51	3.62	6.91	4.28
	2013	2.41	4.08	8.14	5.10	1.35	3.23	7.06	4.13	1.86	3.64	7.58	4.60
	2014	3.13	4.39	8.49	5.51	1.86	2.94	7.44	4.29	2.48	3.64	7.94	4.88
	2015	2.34	3.75	6.93	4.43	1.97	2.85	7.59	4.28	2.15	3.28	7.27	4.35
	2016	1.38	4.92	7.46	4.64	1.75	3.72	8.90	4.89	1.57	4.30	8.21	4.77
Cochran–Armitage test for trend		0.263	0.722	0.408	0.724	0.153	0.040	<0.001	<0.001	0.072	0.103	<0.001	0.002

Table 3.

Gender-specific annual prevalence (per 100,000 persons) of type 1 diabetes mellitus with confidence intervals among Korean children

Year	Girls			Boys			Total
Year	No. of cases	Population	Prevalence (CI)	No. of cases	Population	Prevalence (CI)	No. of cases	Population	Prevalence (CI)
2007	1,501	4,223,530	35.54 (33.76–37.38)	1,417	4,658,230	30.42 (28.86–32.05)	2,918	8,881,760	32.85 (31.67–34.07)
2008	1,466	4,120,183	35.58 (33.78–37.45)	1,361	4,521,648	30.10 (28.52–31.74)	2,827	8,641,831	32.71 (31.52–33.94)
2009	1,416	4,009,329	35.32 (33.50-37.21)	1,337	4,374,659	30.56 (28.95–32.25)	2,753	8,383,987	32.84 (31.62–34.09)
2010	1,403	3,898,029	35.99 (34.13–37.93)	1,305	4,231,154	30.84 (29.19–32.56)	2,708	8,129,182	33.31 (32.07–34.59)
2011	1,374	3,799,250	36.17 (34.28–38.13)	1,233	4,106,239	30.03 (28.37–31.75)	2,607	7,905,489	32.98 (31.72–34.27)
2012	1,400	3,710,279	37.73 (35.78–39.76)	1,260	3,998,855	31.51 (29.79–33.30)	2,660	7,709,134	34.50 (33.21–35.84)
2013	1,288	3,624,293	35.54 (33.62–37.53)	1,116	3,897,014	28.64 (26.98–30.37)	2,404	7,521,307	31.96 (30.70–33.27)
2014	1,298	3,541,088	36.66 (34.69–38.71)	1,117	3,795,828	29.43 (27.73–31.20)	2,415	7,336,916	32.92 (31.62–34.26)
2015	1,201	3,457,143	34.74 (32.80–36.76)	1,109	3,694,212	30.02 (28.28–31.84)	2,310	7,151,354	32.30 (31.00–33.65)
2016	1,361	3,380,577	40.26 (38.15–42.46)	1,242	3,601,440	34.49 (32.59–36.46)	2,603	6,982,017	37.28 (35.86–38.74)
2017	1,456	3,318,119	43.88 (41.66–46.19)	1,352	3,526,103	38.34 (36.33–40.44)	2,808	6,844,221	41.03 (39.52–42.57)

CI, confidence interval.

TOOLS

Similar articles